| Name | E4_HYPERPRO_ADVERSE |
|---|---|
| Long name | Hyperprolactinaemia, drug-induced |
| Hospital Discharge registry | ICD-10: E221 |
| Hospital Discharge: ATC drug used | ANY |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Latin name | Hyperprolactinaemia |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 90 | 82 | 8 |
| Unadjusted prevalence (%) | 0.04 | 0.07 | 0.01 |
| Mean age at first event (years) | 39.07 | 37.74 | 52.65 |
| Case fatality at 5-years (%) | 0.00 | 0.00 | 0.00 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 2.0 |
| Recurrence at 6 months (%) | 30.00 | 29.27 | 37.50 |
before Hyperprolactinaemia, drug-induced
after Hyperprolactinaemia, drug-induced
Loading survival analyses plot…
Loading survival analyses table…